CheckMate 141 trial: all that glitters is not gold

Affiliations

¹ a Oncology Unit , "S. Giovanni di Dio" Hospital , Naples , Italy.
² b Oncology Unit , "Businco" Hospital , Cagliari , Italy.
³ c Department of Pharmacy , University of Naples Federico II , Naples , Italy.
⁴ d U.O.C. ORL, AORN "Cardarelli" , Napoli , Italy.
⁵ e Department of Precision Medicine , University of Campania "L. Vanvitelli" , Naples and Biogem , Avellino Italy.

Editorial

Raffaele Addeo et al. Expert Opin Biol Ther. 2019 Mar.

. 2019 Mar;19(3):169-171.

doi: 10.1080/14712598.2019.1570498. Epub 2019 Jan 21.

¹ a Oncology Unit , "S. Giovanni di Dio" Hospital , Naples , Italy.
² b Oncology Unit , "Businco" Hospital , Cagliari , Italy.
³ c Department of Pharmacy , University of Naples Federico II , Naples , Italy.
⁴ d U.O.C. ORL, AORN "Cardarelli" , Napoli , Italy.
⁵ e Department of Precision Medicine , University of Campania "L. Vanvitelli" , Naples and Biogem , Avellino Italy.

No abstract available

Keywords: Head and neck cancer; cetuximab; immunological check point inhibitors; nivolumab; pembrolizumab.

Comment on

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.
Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington K, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Iglesias Docampo LC, Haddad R, Rordorf T, Kiyota N, Tahara M, Monga M, Lynch M, Geese WJ, Kopit J, Shaw JW, Gillison ML. Ferris RL, et al. N Engl J Med. 2016 Nov 10;375(19):1856-1867. doi: 10.1056/NEJMoa1602252. Epub 2016 Oct 8. N Engl J Med. 2016. PMID: 27718784 Free PMC article. Clinical Trial.